Over the next several days, pharmacies and doctors’ offices are going to start receiving Covid-19 boosters that are reformulated to include protection against one of the sub-variants of Omicron.
These boosters, from Pfizer and its partner BioNTech as well as from Moderna, are bivalent shots. They target two strains of the SARS-CoV-2 virus, both the original strain that all previous vaccines have protected against, and the Omicron sub-variants BA.4/BA.5.
These products received emergency authorizations from the Food and Drug Administration on Wednesday. On Thursday evening, Centers for Disease Control and Prevention Director Rochelle Walensky signed off on the recommendation made earlier in the day by the Advisory Committee on Immunization Practices.
The American Hospital Association has more detailed information on the newly approved shots. Read more by clicking here.